On Wednesday, Capricor Therapeutics Inc (CAPR) stock saw a modest uptick, ending the day at $21.39 which represents a slight increase of $1.25 or 6.21% from the prior close of $20.14. The stock opened ...
On Friday, Capricor Therapeutics Inc (CAPR) stock saw a modest uptick, ending the day at $18.86 which represents a slight increase of $0.37 or 2.00% from the prior close of $18.49. The stock opened at ...
Fintel on MSN2d
Piper Sandler Initiates Coverage of Capricor Therapeutics (CAPR) with Overweight RecommendationFintel reports that on October 21, 2024, Piper Sandler initiated coverage of Capricor Therapeutics (NasdaqCM:CAPR) with a ...
Deep-pocketed investors have adopted a bearish approach towards Capricor Therapeutics CAPR, and it's something market players ...
Capricor Therapeutics shares are trading lower by 2.7% during Thursday's session. The company earlier commenced its public ...
Hosted on MSN16d
Does Capricor (CAPR) Have the Potential to Rally 90.16% as Wall Street Analysts Expect?Capricor Therapeutics (CAPR) closed the last trading session at $18.09, gaining 330.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set ...
Edward Tenthoff, an analyst from Piper Sandler, has initiated a new Buy rating on Capricor Therapeutics (CAPR). Edward Tenthoff’s rating ...
SAN DIEGO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing ...
(RTTNews) - Capricor Therapeutics (NASDAQ: CAPR) Thursday priced its public offering of 4.412 million shares at $17 per share. The company's shares were down more than 12 percent in pre-market.
SAN DIEGO, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback